Document Type : Original Article

Authors

1 Urology

2 General Surgery Kidney

3 Health

4 Raidiology, SKIMS, Srinagar, Kashmir, India

Abstract

Objective: To estimate the incidence of hyperechoic, hypoechoic, isoechoic, prostatic cancer in
TRUS (transrectal ultrasound guided) guided prostatic specimens. Materials and Methods: Four
hundred and ninety three patients with raised serum prostatic specific antigen (PSA) and
abnormal DRE findings were subjected to TRUS‑Guided prostate biopsy. Lateralized sextant
biopsy plus prostatic cores from suspicious areas were obtained. Results: Out of 493 patients
who were enrolled in the study, 65 (13.18) patients showed hyperechoic lesions on TRUS and
211 (42.79) patients had hypoechoic lesions on TRUS. Conclusion: Our study has revealed
that hyperechoic lesions on transrectal ultrasonography have more chances of prostatic
cancer as reported in previous literature, so we suggest that we should take additional biopsy
of hyperechoic lesions and perhaps it should be part of the standard protocol in patients
suspected cancer prostate.

Keywords

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA
Cancer J Clin 1996:46:5‑27.
2. Watanab H, Kato H, Kato T, Morita M, Tanaka M. Diagnostic
application of ultra sono graphy to the prostrate. Nihon Hinyokika
Gakkai Zasshi 1968;59:273‑9.
3. Holm HH, Gammelgard J. Ultrasonically guided precise needle
placement in prostate and seminal vesicles. J Urol 1981;125:385‑7.
4. Durkan GC, Greene DR. Diagnostic dilemmas in ditection of prostate
cancer in patients undergoing transrectal ultrasound‑guided needle
biopsy of the prostate. Prostate Cancer Prostatic Dis 2000;3:13‑20.
5. Loch T, Eppelmann U, Lehmann J, Wullich B, Loch A, Stöckle M.
Transrectal ultrasound guided biopsy of the prostate: Random
sextant versus biopsies of sono‑morophologically suspicious
lesions. World J Urol 2004;22:357‑60.
6. Lihrup PJ, Bailey SE. Prostate cancer: The role of transrectal
ultrasound and its impact on cancer detection and management.
Radiol Clin North Am 2000;38:87‑113.
7. Stilmant MM, Kuligowska E. Trans rectal ultrasound screening for
prostatic adenocarcinoma with histopathologic correlation. Cancer
1993;71:2041‑7.
8. Stroumbakis N, Cookson MS, Reuter VE, Fair WR. Clinical
significance of repeat sextant biopsies in prostate cancer patients.
Urology 1997;49:113‑8.
9. Finne P, Auviena A, Aro J, Juusela H, Määttänen L, Rannikko S,
et al. Estimation of prostate cancer risk on the basis of total and
free prostate specific antigen, prostate volume and digital rectal
examination. Eur Urol 2002;41:619‑27.
10. Egawa S, Wheeler TM, Greene DR, Scardino PT. Unusual
hyperechoic appearance of prostate cancer on transrectal
ultrasonography. Br J Urol 1992;69:169‑74.
11. Shinohara K, Wheeler TM, Scardino PT. The appearance of prostate
cancer on transrectal ultrasonography: Correlation of imaging and
pathological examinations. J Urol 1989;142:76‑8.
12. Malik R, Pandya VK, Naik D. Transrectal ultrasonography for
evaluation of various benign and malignant prostatic lesions and
their histopathological correlation. Ind J Radiol Imag 2004;14:155‑7.